Ignite Creation Date:
2024-05-06 @ 10:14 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03205176
Status:
COMPLETED
Last Update Posted:
2021-05-06
First Post:
2017-06-23
Brief Title:
AZD5153 in Patients With Relapsed or Refractory Solid Tumors Including Lymphomas
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |
| Malignant Solid Tumors |
| Lymphoma |
| Ovarian Cancer |
| Breast Cancer |
| Pancreatic Cancer |